GENERAL (Details Narrative) RM in Millions |
Dec. 26, 2025
MYR (RM)
|
Dec. 12, 2025
SGD ($)
shares
|
Aug. 22, 2025
SGD ($)
|
Dec. 31, 2025
USD ($)
|
Dec. 31, 2025
SGD ($)
|
Dec. 31, 2024
SGD ($)
|
|---|---|---|---|---|---|---|
| IfrsStatementLineItems [Line Items] | ||||||
| Issued capital, amount | $ 19,174,826 | $ 24,656,909 | $ 23,793,950 | |||
| LongevityBank Pte Ltd [member] | ||||||
| IfrsStatementLineItems [Line Items] | ||||||
| Cash consideration | $ 1 | |||||
| Description of diluted equity interest percentage | the effective equity interest held in LongevityBank diluted from 90% to 77% whereas effective equity interest held in Puricell Lab further diluted from 86% to 73%. | the effective equity interest held in Puricell Lab diluted from 95% to 86% | ||||
| Number of shares issued | shares | 140,000 | |||||
| Issued capital, amount | $ 700,000 | |||||
| CytoMed Therapeutics (Malaysia) Sdn Bhd [member] | ||||||
| IfrsStatementLineItems [Line Items] | ||||||
| Cash consideration | RM | RM 7.5 | |||||
| Description of diluted equity interest percentage | the effective equity interest held in CytoMed Malaysia remains at 100%. |